Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Breathe (Sheffield, England)|January 17, 2022
Choosing pharmacotherapy for ILD in patients with connective tissue diseaseZhe Wu, Philip L MolyneauxEuropean Respiratory Review : an Official Journal of the European Respiratory Society|July 10, 2019
The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosisRachele Invernizzi, Philip L MolyneauxEuropean Respiratory Review : an Official Journal of the European Respiratory Society|September 3, 2013
The role of infection in the pathogenesis of idiopathic pulmonary fibrosisPhilip L Molyneaux, Toby M MaherAnnals of Translational Medicine|July 15, 2017
The respiratory microbiome in idiopathic pulmonary fibrosisRichard J Hewitt, Philip L MolyneauxEuropean Respiratory Review : an Official Journal of the European Respiratory Society|March 25, 2026
Progressive pulmonary fibrosis: the importance of identification and interventionPhilip L Molyneaux, Toby M MaherCurrent Opinion in Pulmonary Medicine|June 23, 2025
Precision medicine in rheumatoid arthritis-associated interstitial lung disease: current evidence and future directionsScott M MatsonImmunology|March 21, 2020
Respiratory microbiome and epithelial interactions shape immunity in the lungsRachele Invernizzi, Clare M Lloyd, Philip L MolyneauxERJ Open Research|March 5, 2025
Extracellular vesicles in sarcoidosis: unlocking molecular signatures for precision therapySahil Pandya, Scott M MatsonDrug Design, Development and Therapy|July 3, 2013
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanibHannah V Woodcock, Philip L Molyneaux, Toby M MaherFrontiers in Medicine|May 15, 2018
Clinical Genetics in Interstitial Lung DiseaseChad A Newton, Philip L Molyneaux, Justin M OldhamPageof 18